Anti-ERK2 Antibody (CT) Polyclonal Antibody (OAAI00228)

CLDN4

1364

The extracellular signal-regulated kinases A½ (ERK1/2) are known as MAPK (Mitogen-activated protein kinases) are a widely conserved family of serine/threonine protein kinases involved in many cellular programs such as cell prolifeRation, differentiation, motility, and death. ERK2 is also known as mitogen activated protein kinase 2, microtubule-associated protein-2 kinase, MAP kinse 2, p42-MAPK or EGF receptor T669 (ERT1). The p44/42 MAPK (ERK1/2) signaling pathway can be activated in response to a diverse range of extracellular stimuli including mitogens, growth factors, and cytokines and is an important target in the diagnosis and treatment of cancer. The phosphorylation of MAPK at Thr202 and Tyr 204 are correlated to the progression and metastatic potential of tumor cells.

Polyclonal

Wet Ice